Social disadvantage may amplify dementia risk in people with type 2 diabetes

A large-scale analysis drawing on two national cohorts suggests that the social circumstances in which people live may play a decisive role in shaping dementia risk among those with type 2 diabetes, a population already known to be vulnerable to cognitive decline. The study, published in the journal Aging on September 10, 2026, was conducted by You Lu and Yilin Yoshida of the Section of Endocrinology in the Deming Department of Medicine at Tulane University in New Orleans. Rather than treating social disadvantage as a single factor, the researchers built a weighted, multidomain score of social determinants of health, a measure designed to capture the cumulative and unequal burden of multiple forms of adversity at once. Their central finding was striking: unfavorable social determinants were associated with a substantially higher hazard of dementia in adults with and without type 2 diabetes, and the combination of diabetes and social disadvantage appeared to be more than the sum of its parts, particularly among women.

Social determinants of health encompass the conditions in which people are born, live, work and age, including income, education, housing, neighborhood environment, social connection and psychosocial stress. These factors are increasingly recognized in epidemiology as powerful modifiers of disease outcomes, yet they are often examined one at a time, which can obscure the reality that disadvantages tend to cluster within the same individuals and communities. To address this, the Tulane team used an elastic-net weighting approach, a statistical technique that can handle many correlated variables simultaneously and assign each social indicator a weight reflecting its contribution to the overall score. Participants were then sorted into favorable, medium and unfavorable categories, allowing the investigators to test whether graded levels of cumulative social burden corresponded to graded differences in dementia incidence over time.

The primary analysis drew on the UK Biobank, one of the world’s largest prospective biomedical cohorts, and included 10,071 participants with type 2 diabetes and 11,780 euglycemic participants. Over approximately fourteen years of follow-up, 247 participants with diabetes and 149 euglycemic participants developed dementia. Among people with type 2 diabetes, unfavorable social determinants, compared with favorable ones, were associated with roughly a 2.4-fold higher hazard of dementia after adjustment for a broad set of covariables, including age, race, sex, smoking status, alcohol consumption, physical activity, total cholesterol, body mass index, hemoglobin A1C, depression and an Alzheimer’s disease polygenic risk score. A similar overall association emerged among euglycemic participants, indicating that cumulative social disadvantage matters for cognitive outcomes even in the absence of diabetes.

The most arresting result, however, concerned sex differences. Among men with type 2 diabetes, unfavorable versus favorable social determinants were associated with a 1.7-fold higher dementia risk. Among women with the same disease, the corresponding figure was 5.35-fold, and the statistical test for interaction confirmed that the association between social burden and dementia differed significantly between men and women. This pattern suggests that women with type 2 diabetes may bear a disproportionate cognitive cost when social circumstances are adverse. The authors note that their findings support the evidence that women with type 2 diabetes may be especially vulnerable to the cognitive consequences of social determinants of health, a conclusion with potential implications for how cognitive risk is assessed and how diabetes care is tailored.

The interplay between diabetes and social environment also showed up when the researchers compared people with and without diabetes within the same social strata. Among participants in the medium or unfavorable social determinant categories, those with type 2 diabetes had nearly three times the hazard of dementia compared with euglycemic participants in the same strata. Among women in these categories, diabetes was associated with approximately a 3.1-fold higher risk compared with euglycemic women. In other words, the metabolic disease carried a steeper cognitive penalty in socially disadvantaged settings than it did overall, a pattern consistent with the idea that social adversity and metabolic dysfunction can interact rather than merely add together.

To guard against the possibility that the UK Biobank findings were an artifact of a single population or health system, the team replicated key analyses in the United States All of Us Research Program, a large and diverse national cohort. Similar patterns for both dementia and mild cognitive impairment were observed, lending weight to the conclusion that the association between cumulative social disadvantage and cognitive risk in diabetes is not confined to one country or one set of measurement conventions. Replication across two independently constructed cohorts with different demographic compositions is an important strength in observational research of this kind, where confounding and measurement error are persistent concerns.

Beneath the aggregate score, several individual social indicators stood out. Among UK Biobank participants with type 2 diabetes, dementia was associated with household income, area-level education deprivation, home ownership, loneliness and perceived stress. Household income and loneliness were linked to dementia risk in both men and women, with stronger associations among women, while perceived stress was additionally associated with dementia risk in women with type 2 diabetes. These component-level findings hint at mechanisms: loneliness and chronic stress are known to influence hypothalamic-pituitary-adrenal axis activity, inflammation and health behaviors, while income and housing stability shape access to care, nutritious food and safe opportunities for physical activity.

The authors outline several plausible biological and behavioral pathways that could connect social disadvantage to cognitive decline in diabetes. Social adversity can restrict access to healthcare, healthy food, physical activity and medication adherence, and it can undermine diabetes self-management while amplifying psychosocial stress. These pressures may interact with the vascular and metabolic abnormalities that accompany type 2 diabetes, including microvascular disease, endothelial dysfunction, chronic inflammation and insulin resistance, all of which have been implicated in neurodegeneration and cerebrovascular injury. The brain’s vulnerability to metabolic disease may therefore be compounded when the social environment fails to buffer the demands of managing a chronic condition. The researchers are careful to emphasize, however, that these are observational findings and do not establish that adverse social determinants directly cause dementia.

The study also carries important limitations that temper interpretation. Dementia and mild cognitive impairment were identified using diagnostic codes, a method that can produce misclassification and can miss undiagnosed cases, particularly among people with limited healthcare access, which could itself bias estimates. The social determinant measures differed between the UK Biobank and All of Us and required harmonization, neither cohort fully represents the general population, and residual confounding cannot be excluded despite extensive statistical adjustment. In addition, the neuroimaging and cognitive measures available to the researchers were cross-sectional, which limits the ability to draw mechanistic conclusions about how social conditions translate into brain changes over time.

Looking forward, the authors propose that future studies incorporating longitudinal brain imaging, repeated cognitive assessments, inflammatory markers, proteomics and metabolomics could help clarify the biological routes by which social disadvantage relates to cognitive decline. For now, the findings carry a clear practical message: cumulative social conditions are associated with dementia risk and may be especially consequential for people living with type 2 diabetes, and the markedly stronger association observed among women suggests that both social circumstances and sex deserve a place in cognitive risk assessment and diabetes care. Whether interventions that address adverse social determinants, from income support to loneliness reduction, can actually lower dementia risk remains an open question that only targeted trials and long-term follow-up studies can answer.

Subject of Research: The association between adverse social determinants of health and dementia risk in people with and without type 2 diabetes

Article Title: Adverse social determinants linked to higher dementia risk in people with type 2 diabetes

Article References: Adverse social determinants linked to higher dementia risk in people with type 2 diabetes. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: dementia, type 2 diabetes, social determinants of health, UK Biobank, All of Us Research Program, sex differences, cognitive decline, loneliness, household income, epidemiology, aging, Tulane University